Switch theme
Sign up to access all valuation multiples
Carbiotix AB is a Sweden based pre-clinical stage therapeutics company focused on gut health testing and microbiome modulators to address a range of chronic and metabolic diseases. The products of the company include OneGut, MonthGut, LinkGut, and HealthGut.
2014
9
Last FY Revenue $0.1M
Last FY EBITDA -$1.6M
$5.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Carbiotix achieved revenue of $0.1M and an EBITDA of -$1.6M.
Carbiotix expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Carbiotix valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.1M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.2M | XXX | XXX | XXX |
| Gross Margin | XXX | 178% | XXX | XXX | XXX |
| EBITDA | XXX | -$1.6M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -1616% | XXX | XXX | XXX |
| EBIT | XXX | -$1.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | -1634% | XXX | XXX | XXX |
| Net Profit | XXX | -$1.7M | XXX | XXX | XXX |
| Net Margin | XXX | -1648% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Carbiotix's stock price is SEK 12 (or $1).
Carbiotix has current market cap of SEK 55.0M (or $5.7M), and EV of SEK 53.7M (or $5.5M).
See Carbiotix trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.5M | $5.7M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Carbiotix has market cap of $5.7M and EV of $5.5M.
Carbiotix's trades at 54.9x EV/Revenue multiple, and -3.4x EV/EBITDA.
Equity research analysts estimate Carbiotix's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Carbiotix's P/E ratio is not available.
See valuation multiples for Carbiotix and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5.7M | XXX | $5.7M | XXX | XXX | XXX |
| EV (current) | $5.5M | XXX | $5.5M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 54.9x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -3.4x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -3.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -3.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -2.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCarbiotix's revenue per employee in the last FY averaged $11K, while opex per employee averaged $0.2M for the same period.
Carbiotix's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Carbiotix's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Carbiotix and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -1616% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $11K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 1812% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Carbiotix acquired XXX companies to date.
Last acquisition by Carbiotix was XXXXXXXX, XXXXX XXXXX XXXXXX . Carbiotix acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Carbiotix founded? | Carbiotix was founded in 2014. |
| Where is Carbiotix headquartered? | Carbiotix is headquartered in Sweden. |
| How many employees does Carbiotix have? | As of today, Carbiotix has 9 employees. |
| Is Carbiotix publicy listed? | Yes, Carbiotix is a public company listed on SAT. |
| What is the stock symbol of Carbiotix? | Carbiotix trades under CRBX ticker. |
| When did Carbiotix go public? | Carbiotix went public in 2019. |
| Who are competitors of Carbiotix? | Similar companies to Carbiotix include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Carbiotix? | Carbiotix's current market cap is $5.7M |
| Is Carbiotix profitable? | Yes, Carbiotix is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
